Archivel Technologies

Archivel Technologies is committed to developing R&D projects with clear innovative applications, the use of leading technologies, respect for the environment, and public health. Currently, Archivel Technologies is involved in developing a vaccine to treat tuberculosis infections that have not yet been addressed. The research is being conducted in collaboration with researchers from the Three Kingdoms Medical College Institute at a German university.